These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Deamination of aliphatic amines by type B monoamine oxidase and semicarbazide-sensitive amine oxidase; pharmacological implications. Yu PH, Davis BA, Boulton AA, Zuo DM. J Neural Transm Suppl; 1994 Aug; 41():397-406. PubMed ID: 7931256 [Abstract] [Full Text] [Related]
9. Inhibition of a type B monoamine oxidase inhibitor, (E)-2-(4-fluorophenethyl)-3-fluoroallylamine (MDL-72974A), on semicarbazide-sensitive amine oxidases isolated from vascular tissues and sera of different species. Yu PH, Zuo DM. Biochem Pharmacol; 1992 Jan 22; 43(2):307-12. PubMed ID: 1739419 [Abstract] [Full Text] [Related]
10. Further studies on the ex-vivo effects of procarbazine and monomethylhydrazine on rat semicarbazide-sensitive amine oxidase and monoamine oxidase activities. Holt A, Callingham BA. J Pharm Pharmacol; 1995 Oct 22; 47(10):837-45. PubMed ID: 8583353 [Abstract] [Full Text] [Related]
11. The deamination of n-pentylamine by monoamine oxidase and a semicarbazide-sensitive amine oxidase of rat heart. Guffroy C, Fowler CJ, Strolin Benedetti M. J Pharm Pharmacol; 1983 Jul 22; 35(7):416-20. PubMed ID: 6136581 [Abstract] [Full Text] [Related]
12. In-vivo effects of (E)-2-(3',4'-dimethoxyphenyl)-3-fluoroallylamine (MDL 72145) on amine oxidase activities in the rat. Selective inhibition of semicarbazide-sensitive amine oxidase in vascular and brown adipose tissues. Elliott J, Callingham BA, Barrand MA. J Pharm Pharmacol; 1989 Jan 22; 41(1):37-41. PubMed ID: 2565962 [Abstract] [Full Text] [Related]
13. Properties of a semicarbazide-sensitive amine oxidase in human umbilical artery. Precious E, Lyles GA. J Pharm Pharmacol; 1988 Sep 22; 40(9):627-33. PubMed ID: 2907029 [Abstract] [Full Text] [Related]
14. Studies on human placental monoamine oxidase using mixed substrates. Oguchi K, Kobayashi S, Koide R. Jpn J Pharmacol; 1980 Apr 22; 30(2):157-64. PubMed ID: 7452967 [Abstract] [Full Text] [Related]
15. [Liver monoamine oxidase activity of the lamprey Lampetra fluviatilis. the substrate-inhibitory specificity]. Iagodina OV, Basova IN. Zh Evol Biokhim Fiziol; 2013 Apr 22; 49(1):39-43. PubMed ID: 23662480 [Abstract] [Full Text] [Related]
16. Multiple forms of amine oxidase in perfused rabbit lung. Roth JA, Gillis CN. J Pharmacol Exp Ther; 1975 Sep 22; 194(3):537-44. PubMed ID: 1159630 [Abstract] [Full Text] [Related]
19. Substrate specificity of the different forms of monoamine oxidase in rat liver mitochondria. Ekstedt B. Biochem Pharmacol; 1976 May 15; 25(10):1133-8. PubMed ID: 938537 [No Abstract] [Full Text] [Related]
20. Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide. Visentin V, Bour S, Boucher J, Prévot D, Valet P, Ordener C, Parini A, Carpéné C. Eur J Pharmacol; 2005 Oct 17; 522(1-3):139-46. PubMed ID: 16202994 [Abstract] [Full Text] [Related] Page: [Next] [New Search]